Differences in presentation, severity and management of DKA in type 1 and type 2 diabetes during the COVID-19 pandemic

Clin Med (Lond). 2021 Mar;21(Suppl 2):1-2. doi: 10.7861/clinmed.21-2-s1.

Affiliations

¹ University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
² University of Birmingham, Birmingham, UK, and University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
³ University of Birmingham, Birmingham, UK.
⁴ University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK, and Aston University, Birmingham, UK.

PMID: 34078672
DOI: 10.7861/clinmed.21-2-s1

No abstract available

MeSH terms

COVID-19*
Diabetes Mellitus, Type 2* / complications
Diabetes Mellitus, Type 2* / epidemiology
Diabetic Ketoacidosis* / epidemiology
Diabetic Ketoacidosis* / therapy
Humans
Pandemics
SARS-CoV-2